Search results
Is this FTSE 100 behemoth about to make investors rich all over again?
Motley Fool UK· 5 hours agoFTSE 100 behemoth AstraZeneca (LSE:AZN) is on the verge of becoming a £200bn company. AstraZeneca is...
My son died after the AstraZeneca vaccine gave him a blood clot
Daily Mail· 4 days agoLisa died in May 2021, aged just 44, after complications following the AstraZeneca vaccine led to...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance UK· 6 days agoAstrazeneca (AZN) closed the most recent trading day at $80.21, moving +0.24% from the previous...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance UK· 5 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca...
If I’d invested £5,000 in AstraZeneca shares 5 years ago, here’s what I’d have now
Fool.co.uk via Yahoo Finance UK· 6 days agoWhen it comes to beating the market, AstraZeneca shares have more than delivered. If only our writer...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance UK· 3 days agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance UK· 6 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 3 days agoAstraZeneca (AZN) has long been in the oncology and other disease spaces, but rose to popularity in...
Devastated family of young actor killed by Covid jab speak out
Daily Mail· 6 days agoThe devastated family of a fit and healthy young actor who died a fortnight after taking a Covid vaccine have called out the callous 'indifference' of society and government to her death. Katie ...
Tempus AI shares jump 8% in strong Nasdaq debut as US IPO market thaws
Reuters via Yahoo Finance UK· 2 days agoTempus' customers include major drugmakers such as AstraZeneca and GSK. It competes with Swiss...